Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
35 /100
MEDIUM RISK
Score updated Oct 13, 2026

VIR — Vir Biotechnology, Inc. Dilution Risk Tracker

Track VIR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track VIR — Get alerts when the score changes →

As of October 13, 2026, Vir Biotechnology, Inc. (VIR) has a DilutionWatch DilutionScore of 35/100, rated MEDIUM dilution risk. Vir Biotechnology, Inc. has a market capitalization of $1.98B, 169.22M shares outstanding, 257 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $300.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
32
💰 Cash Runway
40
📊 Float Risk
22
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 9%
💰 Capital Raise model 18%
• Active ATM program with $300M remaining capacity
🔔 Track VIR — Get forecast alerts →

Market Data

Market Cap$1.98B
Shares Outstanding169.22M
Float128.81M
Cash$528.59M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore35/100DilutionWatch score record
Shares Outstanding169.22MVerified float table or market cache
Public Float128.81MVerified float table or market cache
Market Cap$1.98BMarket data cache
Cash Runway14.2 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM Capacity$300.00MSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 5, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 36.4% shares (2026Q1 vs prior)
257 institutional holders · 160.50M shares
#1 BlackRock, Inc. 18.00M shares
#2 ARCH Venture Management, LLC 12.92M shares
#3 SB INVESTMENT ADVISERS (UK) LTD 10.95M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest14.98M
Days to Cover7.0
% of Float11.6%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2022-02-28
4 INSIDER TRANSACTION 2026-04-07
4 INSIDER TRANSACTION 2026-04-02
4 INSIDER TRANSACTION 2026-03-24
4 INSIDER TRANSACTION 2026-03-23
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual VIR Dilution Snapshot

Vir Biotechnology, Inc. (VIR) has a DilutionScore of 35/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

VIR's DilutionScore has held steady at 35/100 (Medium risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 16 – Oct 13, 202635/100MEDIUM89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

VIR shares outstanding have increased 7.3% from 157.16M (Mar 2026) to 168.65M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 21, 2026168.65M128.81M▲ 1.71%
May 16, 2026168.65M126.65M▲ 1.55%
May 10, 2026168.65M124.72M▲ 0.02%
May 09, 2026168.65M124.69M▲ 20.88%
Apr 26, 2026161.23M103.15M▲ 0.31%
Apr 18, 2026161.23M102.83M▲ 0.02%
Apr 10, 2026159.81M102.81M▲ 0.06%
Mar 14, 2026159.81M102.74M▲ 0.02%
Mar 08, 2026157.16M102.72M▲ 0.12%
Mar 07, 2026157.16M102.60M▲ 0.29%
Mar 05, 2026157.16M102.31M▲ 8.01%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track VIR Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment VIR files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking VIR — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for VIR
VIR FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.